News | Note

LENVATIB® The strength to continue



May 1, 2019

We are pleased to inform the community, the new launch of Varifarma. BRUNITIC®, with indications for progressive or advanced thyroid cancer in adults who have been unsuccessfully subjected to a radioactive iodine treatment.

LENVATIB®  The strength to continue